Still Don't See Basic Drug Discovery Capabilities In India: Novartis

Still Don't See Basic Drug Discovery Capabilities In India: Novartis

Novartis ruling shows India doesn't want innovation: Peter Pitts

NDTV

Novartis in 360 Ɩ See how robots aid drug discovery

Novartis CEO discusses how AI will impact drug development

Novartis says it will stick with drug development in India

Drug discovery and development process

Connecting the Dots in Early Drug Discovery at Novartis

Machine learning in action during drug discovery

Virtual reality in drug discovery

Working in drug discovery: Innovation in action

A look inside the Genomics Institute of the Novartis Research Foundation

Novartis Pharma’s Lutz Hegemann: India Is A Very Prosperous Generic Industry

India rules against Novartis in cancer drug case

DRUG FIRMS NEED TO LOWER COST OF DRUG DEVELOPMENT: VAS NARASIMHAN, NOVARTIS

Drug discovery with DNA-encoded libraries

Novartis

Doctors Without Borders / MSF-USA

2010 CEO Innovation Lecture Dan Vasella, Novartis

Rothman Institute of Entrepreneurship at Fairleigh Dickinson University

Novartis verdict: A lifesaver of poor cancer patients in India?

NDTV

Accelerating Drug Development in the Snowflake Data Cloud | Novartis

Novartis CEO on the challenges of drugs coming off patent

David Rubenstein